Explore

Trendline Trendline
Mineralys Therapeutics Reports Financial Results and Prepares for Lorundrostat Launch

Mineralys Therapeutics Reports Financial Results and Prepares for Lorundrostat Launch

Mineralys Therapeutics Reports Financial Results and Prepares for Lorundrostat Launch
Trendline Trendline
Lakefront Biotherapeutics Reports Financial Results and Strategic Updates

Lakefront Biotherapeutics Reports Financial Results and Strategic Updates

Lakefront Biotherapeutics Reports Financial Results and Strategic Updates
Trendline Trendline
BridgeBio Reports Strong Q2 2026 Financial Results and Advances in Drug Development

BridgeBio Reports Strong Q2 2026 Financial Results and Advances in Drug Development

BridgeBio Reports Strong Q2 2026 Financial Results and Advances in Drug Development
Trendline Trendline
Sagimet Biosciences Reports $14 Million Q2 Loss, Plans Phase 3 Acne Trial

Sagimet Biosciences Reports $14 Million Q2 Loss, Plans Phase 3 Acne Trial

Sagimet Biosciences Reports $14 Million Q2 Loss, Plans Phase 3 Acne Trial
Trendline Trendline
Veru Inc. Advances Obesity Treatment with Novo Nordisk Partnership and Reports Q3 2026 Financials

Veru Inc. Advances Obesity Treatment with Novo Nordisk Partnership and Reports Q3 2026 Financials

Veru Inc. Advances Obesity Treatment with Novo Nordisk Partnership and Reports Q3 2026 Financials
Trendline Trendline
Aura Biosciences Reports Increased Net Loss in Q2 2026 Amid Clinical Advancements

Aura Biosciences Reports Increased Net Loss in Q2 2026 Amid Clinical Advancements

Aura Biosciences Reports Increased Net Loss in Q2 2026 Amid Clinical Advancements
Trendline Trendline
Immunic Inc. Raises $200M Amid Widening Losses in Q2 2026

Immunic Inc. Raises $200M Amid Widening Losses in Q2 2026

Immunic Inc. Raises $200M Amid Widening Losses in Q2 2026
Trendline Trendline
Veradermics Reports Strong Financial Position and Progress in Hair Loss Treatment Development

Veradermics Reports Strong Financial Position and Progress in Hair Loss Treatment Development

Veradermics Reports Strong Financial Position and Progress in Hair Loss Treatment Development
Trendline Trendline
Tenax Therapeutics' Heart Failure Drug Fails in Pivotal Phase 3 Study

Tenax Therapeutics' Heart Failure Drug Fails in Pivotal Phase 3 Study

Tenax Therapeutics' Heart Failure Drug Fails in Pivotal Phase 3 Study
Trendline Trendline
OmniAb Reports Strong Quarterly Performance Driven by Partner Milestones

OmniAb Reports Strong Quarterly Performance Driven by Partner Milestones

OmniAb Reports Strong Quarterly Performance Driven by Partner Milestones
Trendline Trendline
Axsome Therapeutics Reports Strong Financial Growth and New Product Launches in Q2 2026

Axsome Therapeutics Reports Strong Financial Growth and New Product Launches in Q2 2026

Axsome Therapeutics Reports Strong Financial Growth and New Product Launches in Q2 2026
Trendline Trendline
SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure

SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure

SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure